Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-28

Clinical Trial Update: Dextro-Amphetamine Versus Caffeine in Treatment-resistant OCD [NA]

View source ↗

Summary

A clinical trial comparing dextro-amphetamine and caffeine for treatment-resistant obsessive-compulsive disorder has completed, with results posted in March 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Caffeine (caffeine)
  • Dextro-amphetamine (dextroamphetamine)

Snippet

Sponsor: Stanford University | Conditions: Obsessive-Compulsive Disorder | NA | Status: COMPLETED | Results posted: 2017-03-28